Literature DB >> 527268

Blood lymphocyte subpopulations in breast cancer patients following post-operative adjuvant chemotherapy or radiotherapy.

B Petrini, J Wasserman, H Blomgren, E Baral, L E Strender, A Wallgren.   

Abstract

The peripheral lymphocyte population was examined in sixty-five randomized breast cancer patients before and after post-operative adjuvant cyclic chemotherapy or local radiation therapy. During 10 months of chemotherapy total lymphocyte and T cell counts were reduced to 70% and non-T cells to about 50% of pretreatment values. The population of T cells was unaltered whereas the proportion of non-T cells was significantly reduced at the end of the period. Immediately after radiotherapy total lymphocyte and T cell counts were reduced to 30%, and non-T cells to 15% of pretreatment values. During 10 months' observation total lymphocyte and T cell counts increased to 70%, and non-T cells to 50--60% of pretreatment values.

Entities:  

Mesh:

Year:  1979        PMID: 527268      PMCID: PMC1537858     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Effects of local irradiation (Co60 teletherapy) on the peripheral blood and bone marrow.

Authors:  F A GOSWITZ; G A ANDREWS; R M KNISELEY
Journal:  Blood       Date:  1963-05       Impact factor: 22.113

2.  Effect of radiotherapy on blood lymphocyte population in mammary carcinoma.

Authors:  H Blomgren; R Berg; J Wasserman; U Glas
Journal:  Int J Radiat Oncol Biol Phys       Date:  1976 Jan-Feb       Impact factor: 7.038

3.  Blood lymphocytes in breast cancer patients following radiotherapy and surgery.

Authors:  E Baral; H Blomgren; B Petrini; J Wasserman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1977 Mar-Apr       Impact factor: 7.038

4.  T- and B-lymphocyte subpopulations following radiotherapy for invasive squamous cell carcinoma of the uterine cervix.

Authors:  R J Rand; D M Jenkins; R Bulmer
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

5.  Blood lymphocyte subpopulations in breast cancer patients following radiotherapy.

Authors:  B Petrini; J Wasserman; H Blomgren; E Baral
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

6.  Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma.

Authors:  J Stjernswärd; M Jondal; F Vánky; H Wigzell; R Sealy
Journal:  Lancet       Date:  1972-06-24       Impact factor: 79.321

7.  Blood lymphocytes after radiation therapy of mammary carcinoma.

Authors:  H Blomgren; U Glas; B Melén; J Wasserman
Journal:  Acta Radiol Ther Phys Biol       Date:  1974-06

8.  Preoperative radiotherapy in operable breast cancer: results in the Stockholm Breast Cancer Trial.

Authors:  A Wallgren; O Arner; J Bergström; B Blomstedt; P O Granberg; L Karnström; L Räf; C Silfverswärd
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

9.  Combination chemotherapy as an adjuvant treatment in operable breast cancer.

Authors:  G Bonadonna; E Brusamolino; P Valagussa; A Rossi; L Brugnatelli; C Brambilla; M De Lena; G Tancini; E Bajetta; R Musumeci; U Veronesi
Journal:  N Engl J Med       Date:  1976-02-19       Impact factor: 91.245

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

  10 in total
  3 in total

1.  Acute severe lymphopenia by radiotherapy is associated with reduced overall survival in hepatocellular carcinoma.

Authors:  Hwa Kyung Byun; Nalee Kim; Sangjoon Park; Jinsil Seong
Journal:  Strahlenther Onkol       Date:  2019-04-15       Impact factor: 3.621

2.  Transient lymphocyte decrease due to adhesion and migration following catumaxomab (anti-EpCAM x anti-CD3) treatment in vivo.

Authors:  Kirsten Dettmar; Isabell Seitz-Merwald; Carsten Lindemann; Petra Schroeder; Diane Seimetz; Judith Atz
Journal:  Clin Transl Oncol       Date:  2012-05       Impact factor: 3.405

3.  Delayed recovery of peripheral blood cell numbers after adjuvant cytotoxic chemotherapy for stage II breast cancer.

Authors:  M D Goodyear; I R Mackay; I S Russell
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.